Long Road to Ruin: Noradrenergic Dysfunction in Neurodegenerative Disease

Trends in Neurosciences
David Weinshenker

Abstract

It has been known for decades that degeneration of the locus coeruleus (LC), the major noradrenergic nucleus in the brain, occurs in both Alzheimer's disease (AD) and Parkinson's disease (PD), but it was given scant attention. It is now recognized that hyperphosphorylated tau in the LC is the first detectable AD-like neuropathology in the human brain, α-synuclein inclusions in the LC represent an early step in PD, and experimental LC lesions exacerbate neuropathology and cognitive/behavioral deficits in animal models. The purpose of this review is to consider the causes and consequences of LC pathology, dysfunction, and degeneration, as well as their implications for early detection and treatment.

References

Sep 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·R AdolfssonB Winblad
Nov 1, 1992·Annals of Neurology·D C GermanD M Mann
Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Feb 8, 1990·The Journal of Comparative Neurology·Y MoritaM Tohyama
Jun 30, 1987·Brain Research·A M PalmerJ S Snowden
Dec 1, 1986·Journal of the Neurological Sciences·B MarcyniukP O Yates
Nov 1, 1965·The American Journal of Psychiatry·J J Schildkraut
Dec 1, 1965·Archives of General Psychiatry·W E Bunney, J M Davis
Jan 1, 1983·Neuropathology and Applied Neurobiology·D M Mann, P O Yates
Jun 1, 1980·The British Journal of Psychiatry : the Journal of Mental Science·D M MannS Toper
May 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·S L FooteF E Bloom
Feb 1, 1994·Journal of Neurochemistry·G A OrdwayJ W Haycock
Jan 1, 1993·Journal of Neural Transmission. General Section·J GrenhoffT H Svensson
Aug 26, 1998·Neurology·O Hornykiewicz
Jan 23, 1999·Annals of Neurology·W J HoogendijkD F Swaab
Nov 24, 1999·Biological Psychiatry·K J Ressler, C B Nemeroff
Mar 21, 2002·Biological Psychiatry·Kim L MatthewsPaul T Francis
Mar 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Veronica A AlvarezJohn T Williams
May 28, 2002·Journal of Neuropathology and Experimental Neurology·Kelly Del TrediciHeiko Braak
Dec 14, 2002·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Riina HäidkindJaanus Harro
Dec 25, 2002·Neurobiology of Aging·Heiko BraakEva Braak
Apr 2, 2003·Brain Research. Brain Research Reviews·Craig W Berridge, Barry D Waterhouse
Sep 21, 2004·The Journal of Neuropsychiatry and Clinical Neurosciences·Nathan HerrmannLyla R Khan
Jan 6, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jesse R SchankDavid Weinshenker
Jan 13, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Patricia SzotMurray A Raskind
Feb 3, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Michael T HenekaMatthias Staufenbiel
Apr 14, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·George K TofarisMaria Grazia Spillantini
Apr 10, 2007·Biochemical Pharmacology·K S Rommelfanger, D Weinshenker
Aug 19, 2007·Proceedings of the National Academy of Sciences of the United States of America·K S RommelfangerD Weinshenker
Sep 28, 2007·Current Medicinal Chemistry·Francesco FornaiAntonio Paparelli
Jun 10, 2008·Current Alzheimer Research·David Weinshenker
Jan 21, 2009·Neurobiology of Aging·Evangelos SotiriouLeonidas Stefanis
Feb 5, 2009·Nature Reviews. Neuroscience·Susan J Sara
Aug 25, 2009·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Lucy Y WangElaine R Peskind

❮ Previous
Next ❯

Citations

Sep 20, 2018·PloS One·Roger PamphlettPhilip A Doble
May 12, 2018·Acta Neuropathologica Communications·Martin Timo HenrichWolfgang Hermann Oertel
Jun 10, 2019·Journal of Alzheimer's Disease : JAD·Sarah C KellyScott E Counts
Sep 11, 2019·Nature Human Behaviour·Martin J DahlMarkus Werkle-Bergner
Jul 11, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Wolfgang H OertelFanni F Geibl
Dec 4, 2019·The Journal of Clinical Investigation·Seong Su KangKeqiang Ye
Jul 22, 2019·Brain : a Journal of Neurology·Matthew J BettsDorothea Hämmerer
Feb 6, 2020·Acta Neuropathologica Communications·Sanne Simone KaalundJames B Rowe
Aug 4, 2020·Journal of Alzheimer's Disease : JAD·Daniele CaligioreGianluca Baldassarre
Sep 19, 2020·Nature Reviews. Neuroscience·Gina R PoeSusan J Sara
Oct 23, 2019·Nature Neuroscience·Dilek Mercan, Michael T Heneka
Aug 30, 2020·Experimental & Molecular Medicine·Seong Su KangKeqiang Ye
Feb 24, 2019·International Journal of Molecular Sciences·Mitsuhiro MoritaMami Noda
Mar 22, 2020·Neurotoxicity Research·Xiaoli LiuPeng Shi
Jul 28, 2020·Frontiers in Immunology·Sarah Leach, Kazuhiro Suzuki
Sep 19, 2018·Journal of Alzheimer's Disease : JAD·Alexander J EhrenbergLea T Grinberg
Jul 30, 2019·Annals of Clinical and Translational Neurology·Pauline OlivieriMarie Sarazin
Jan 27, 2021·Neuroscience and Biobehavioral Reviews·Francesco Fornai, Stefano Puglisi-Allegra
Jan 29, 2021·Neurobiology of Aging·Shelby L BachmanMara Mather
Sep 15, 2020·Life Sciences·Vivek Kumar Sharma, Thakur Gurjeet Singh
Dec 29, 2020·Journal of Parkinson's Disease·Michael F SalvatoreVicki A Nejtek
Dec 15, 2020·Current Neurology and Neuroscience Reports·Alessandro GalganiFilippo Sean Giorgi
Feb 9, 2021·Journal of Alzheimer's Disease : JAD·Joost M RiphagenHeidi I L Jacobs
Nov 20, 2020·International Journal of Molecular Sciences·Filippo Sean GiorgiFrancesco Fornai
Oct 31, 2020·Frontiers in Neuroscience·Michael KelbermanDavid Weinshenker
Feb 3, 2021·International Journal of Molecular Sciences·Rola A Bekdash
Jan 16, 2021·Nature and Science of Sleep·Danielle WassermanIvana Rosenzweig
May 1, 2021·Journal of Clinical Medicine·Ágoston PatthyAlán Alpár
May 1, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Larisa RyskalinFrancesco Fornai
May 5, 2021·Journal of Neural Transmission·Filippo Sean GiorgiFrancesco Fornai
Jun 7, 2021·Biogerontology·Aleksei G Golubev
May 31, 2021·Clinical Neurology and Neurosurgery·Paul J Fitzgerald
Jun 12, 2021·NeuroImage·S G Mueller, A M Muller

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Early Markers

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive and behavioral decline. Targeting markers in the earliest stages of the disease may mitigate the progression of AD. This feed focuses on early diagnosis and markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.